tradingkey.logo

Medicus Pharma Announces Positively Trending Interim Analysis For SKNJCT-003 Phase 2 Clinical Study

ReutersMar 6, 2025 12:50 PM

- Medicus Pharma Ltd MDCX.O:

  • MEDICUS PHARMA LTD ANNOUNCES POSITIVELY TRENDING INTERIM ANALYSIS FOR SKNJCT-003 PHASE 2 CLINICAL STUDY TO NON-INVASIVELY TREAT BASAL CELL CARCINOMA OF THE SKIN (BCC)

  • MEDICUS PHARMA LTD: D-MNA WAS WELL TOLERATED FOR BOTH DOSE LEVELS

  • MEDICUS PHARMA: PLANS TO SUBMIT ANALYSIS TO FDA UNDER PACKAGE SEEKING TYPE C MEETING WITH FDA IN Q2

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI